These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 165827)

  • 21. Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia.
    Gotto AM; Brown WV; Levy RI; Birnbaumer ME; Fredrickson DS
    J Clin Invest; 1972 Jun; 51(6):1486-94. PubMed ID: 4336942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Change in the apoproteins of very low density lipoproteins in the blood in hypertriglyceridemia].
    Perova NV; Gerasimova EN; Chernysheva NP; Nikitina NA; Shcherbakova IA
    Vopr Med Khim; 1979; 25(2):185-92. PubMed ID: 220803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Studies with 14C-cholesterol in homozygotic hyperlipemia type IIa].
    Gärtner U; Altrogge H; Sieg K; Becker K; Bläker F
    Verh Dtsch Ges Inn Med; 1975; 81():1434-8. PubMed ID: 179240
    [No Abstract]   [Full Text] [Related]  

  • 24. Solid phase radioimmunoassay of apolipoprotein B (apo B) in normal human plasma.
    Thompson GR; Birnbaumer ME; Levy RI; Gotto AM
    Atherosclerosis; 1976; 24(1-2):107-18. PubMed ID: 182180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein B levels and altered lipoprotein composition in diabetes.
    Schonfeld G; Birge C; Miller JP; Kessler G; Santiago J
    Diabetes; 1974 Oct; 23(10):827-34. PubMed ID: 4371149
    [No Abstract]   [Full Text] [Related]  

  • 26. Metabolism of rat plasma very low density lipoprotein. I. Fate in circulation of the whole lipoprotein.
    Eisenberg S; Rachmilewitz D
    Biochim Biophys Acta; 1973 Dec; 326(3):378-90. PubMed ID: 4359866
    [No Abstract]   [Full Text] [Related]  

  • 27. Composition of low-density lipoprotein in children with hyperlipoproteinaemia.
    Bagnall TF; Lloyrd JK
    Clin Chim Acta; 1975 Mar; 59(3):271-6. PubMed ID: 165017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clofibrate raises plasma apoprotein A-I and HDL-cholesterol concentrations.
    Nestel PJ; Hunt D; Wahlqvist ML
    Atherosclerosis; 1980 Dec; 37(4):625-9. PubMed ID: 7459005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Origin and fate of lipoproteins.
    Bilheimer DW; Levy RI
    Adv Exp Med Biol; 1973; 38():39-52. PubMed ID: 4358292
    [No Abstract]   [Full Text] [Related]  

  • 30. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The carbohydrate composition of human apo low density lipoprotein from normal and type II hyperlipoproteinemic subjects.
    Lee P; Breckenridge WC
    Can J Biochem; 1976 Jan; 54(1):42-9. PubMed ID: 175902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins.
    Utermann G; Jaeschke M; Menzel J
    FEBS Lett; 1975 Aug; 56(2):352-5. PubMed ID: 169165
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Al-chlorophenoxyisobutyrate (Alufibrate) on pyruvate metabolism and on the fate of very low density lipoprotein lipids in hyperlipidemic patients.
    Stähelin HB; Locher JT; Maier R
    Clin Chim Acta; 1974 Jul; 54(1):115-22. PubMed ID: 4367872
    [No Abstract]   [Full Text] [Related]  

  • 35. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor.
    Bowler A; Redgrave TG; Mamo JC
    Biochem J; 1991 Jun; 276 ( Pt 2)(Pt 2):381-6. PubMed ID: 2049068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudohomozygous and pseudoheterozygous type II hyperlipoproteinemia.
    Mishkel MA
    Am J Dis Child; 1976 Sep; 130(9):991-3. PubMed ID: 183495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome.
    Joven J; Villabona C; Vilella E; Masana L; Albertí R; Vallés M
    N Engl J Med; 1990 Aug; 323(9):579-84. PubMed ID: 2381443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein of the low density lipoprotein of human plasma: structural study in familial hyperbetalipoproteinemia.
    Pinon JC; Turpin G
    Clin Chim Acta; 1976 Jul; 70(2):259-65. PubMed ID: 182415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.
    Bilheimer DW; Stone NJ; Grundy SM
    J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperlipoproteinemia type IV and pre-beta-lipoprotein. Some new aspects of its physiology, pathogenesis and diagnosis.
    Wille LE
    J Oslo City Hosp; 1972; 22(11):169-84. PubMed ID: 4344735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.